Potassium iodide (KI) under AICIS
KI · 碘化钾
Status: Listed. Potassium iodide is on the AICIS Inventory of Industrial Chemicals as a Listed Industrial Chemical. **SUSMP / Poisons Standard Schedule 2 / unscheduled at therapeutic concentrations typically** (verify exact schedule + concentration threshold against the current Poisons Standard before relying). **Drug Precursor scope determination under Crimes Legislation Amendment (Drug Precursors) Act 2008 administered by Department of Home Affairs may apply to KI as iodine salt** (verify against https://www.homeaffairs.gov.au/ before invoicing). NO active Australian AD/CVD case on Chinese-origin potassium iodide currently. ChAFTA preferential zero-duty applies for Chinese-origin imports. **TGA registers potassium iodide as therapeutic anti-thyroid radiation tablet (KI tablets distributed under National Medical Stockpile for radiation emergencies) + expectorant + thyroid hormone synthesis precursor** (verify against https://www.tga.gov.au/). **FSANZ Standard 2.10.2 mandatory iodine fortification of bread (since 2009)** (verify against https://www.foodstandards.gov.au/ before relying).
AICIS treats potassium iodide as a Listed Industrial Chemical with **SUSMP Schedule 2 / unscheduled at therapeutic concentrations + Drug Precursor scope-determination overlay (Crimes (Drug Precursors) Act 2008, Department of Home Affairs)**. NO active Australian AD/CVD. ChAFTA preferential zero-duty. **TGA therapeutic KI tablets for nuclear-incident radiation prophylaxis (National Medical Stockpile) + FSANZ Standard 2.10.2 mandatory iodine fortification of bread (since 2009)**. Australia limited domestic production; structurally net-importer.
Listing and threshold
| Substance | Potassium iodide (KI) (CAS 7681-11-0), KI |
|---|---|
| Regime | Australian Industrial Chemicals Introduction Scheme (AICIS), administered by the Department of Health |
| Jurisdiction | Australia |
| Status | Listed |
| Tonnage threshold | AICIS introducer registration required for >100 kg/year |
Classifications under this regime
- Listed Industrial Chemical on AICIS Inventory
- Australian GHS classification: Eye Irrit. 2 + STOT RE 1 thyroid chronic high-dose (verify against current Safe Work Australia HCIS at https://hcis.safeworkaustralia.gov.au/ before relying)
- **SUSMP / Poisons Standard Schedule 2 / unscheduled at therapeutic concentrations typically** (verify exact schedule against the current Poisons Standard before relying)
- **Drug Precursor scope determination under Crimes (Drug Precursors) Act 2008** (verify against https://www.homeaffairs.gov.au/ before relying)
- ADG 7.7: NOT regulated as dangerous goods at solid form
- Safe Work Australia: no specific WES typically established (verify against the current Safe Work Australia Workplace Exposure Standards at https://www.safeworkaustralia.gov.au/exposure-standards before relying)
- **TGA therapeutic KI tablets for radiation emergencies (National Medical Stockpile) + expectorant** (verify against https://www.tga.gov.au/)
- **FSANZ Standard 2.10.2 mandatory iodine fortification of bread (since 2009)** (verify against https://www.foodstandards.gov.au/)
- IARC: Not classified
Restrictions and conditions of use
- **SUSMP / Poisons Standard Schedule 2 / unscheduled at therapeutic concentrations (verify)**
- **Drug Precursor scope determination required (Department of Home Affairs)** (verify against https://www.homeaffairs.gov.au/)
- NO active Australian AD/CVD case on Chinese-origin potassium iodide
- WHS Regulation 2011 (light hazard handling)
- ChAFTA preferential zero-duty applies (HS 283120)
- **TGA therapeutic KI tablets**
- **FSANZ mandatory iodine fortification of bread per Standard 2.10.2 (since 2009)**
Importer obligations
AICIS registration required. **Drug Precursor scope determination required under Crimes (Drug Precursors) Act 2008** (verify against https://www.homeaffairs.gov.au/ before invoicing). Australia has limited domestic potassium iodide production; structurally net-importer for iodised-salt + pharma + animal-feed + photographic sectors.
Required documents
- AICIS registration certificate (annual)
- **End User Declaration (EUD) for drug-precursor scope determination** per Department of Home Affairs
- WHS-compliant SDS (Eye Irrit. 2 + STOT RE 1 thyroid chronic high-dose)
- Customs entry (ICS / ABF) with HS 283120
- ChAFTA Form CO
- TGA certification where placed as therapeutic
- FSANZ documentation where placed as iodised-salt fortification grade
Common compliance traps
The pitfalls that have bitten importers on this lane in the past. None of these is theoretical.
- AICIS registration must be CURRENT at customs clearance
- **SUSMP / Poisons Standard Schedule 2 / unscheduled at therapeutic concentrations**
- **Drug Precursor scope determination required (Department of Home Affairs) under Crimes (Drug Precursors) Act 2008**
- NO active Australian AD/CVD case
- ChAFTA preferential zero-duty applies
- **TGA therapeutic KI tablets for radiation emergencies (National Medical Stockpile) + FSANZ Standard 2.10.2 mandatory iodine fortification of bread (since 2009)**
- Australia limited domestic KI production; structurally net-importer
Where to read next
For substance-level identifiers (formula, molecular weight, SMILES, InChIKey), GHS hazard profile, IMDG transport class, and full sourcing reference for potassium iodide (ki), see the CAS 7681-11-0 sourcing reference.
For grade-by-grade buying notes, freight maths, supplier-tier pricing, and a worked landed-cost example, the potassium iodide (ki) cornerstone hub covers the full sourcing chain.
For the structure and history of AICIS, see the AICIS glossary entry.
Need cross-jurisdiction compliance support on this substance? Run it through the REACH / TSCA / IECSC / AICIS / K-REACH checker, or send us the substance and the destination and we will quote FOB China and CIF / DDP landed including the regulatory work on the destination side.
Read next
Cross-jurisdiction profile and sourcing references
Regulatory
Potassium iodide (KI) under REACH
European Union listing status, classifications, importer obligations.
Regulatory
Potassium iodide (KI) under TSCA
United States of America listing status, classifications, importer obligations.
Regulatory
Potassium iodide (KI) under IECSC
People's Republic of China listing status, classifications, importer obligations.
Regulatory
Potassium iodide (KI) under K-REACH
Republic of Korea listing status, classifications, importer obligations.
CAS
CAS 7681-11-0 sourcing reference
Identifiers, hazard profile, IMDG transport class, and supplier geography for Potassium iodide (KI).
Glossary
AICIS, Australian Industrial Chemicals Introduction Scheme
Australian regulatory scheme for industrial chemicals. Replaced NICNAS in July 2020. Categorises chemical introductions by risk and assigns annual reporting obligations to importers and manufacturers.
Referenced in
5 pages across the Sourzi moat
This term shows up in 4 regulatory pages, 1 CAS profiles. Sample backlinks per content type below.
Regulatory (4)
Potassium iodide (KI) under REACH
European Union compliance profile for Potassium iodide (KI).
Potassium iodide (KI) under TSCA
United States of America compliance profile for Potassium iodide (KI).
Potassium iodide (KI) under IECSC
People's Republic of China compliance profile for Potassium iodide (KI).
Plus 1 more regulatory pages.
Free download
Free PDF: the same MSDS verification template the Sourzi team uses to cross-reference factory documents against TSCA, REACH, AICIS, and CDR before booking.